Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk.


Evaluation of metabolic disturbances has had an important role in the modification of oral contraceptive formulations toward estrogen-progestin combinations with reduced adverse metabolic impact. An increasing number of interrelationships between metabolic risk factors for cardiovascular disease are being recognized, and a metabolic syndrome of disturbances… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.